Targeting the HGF-cMET Axis in Hepatocellular Carcinoma
Open Access
- 31 March 2013
- journal article
- review article
- Published by Hindawi Limited in International Journal of Hepatology
- Vol. 2013, 1-11
- https://doi.org/10.1155/2013/341636
Abstract
Under normal physiological conditions, the hepatocyte growth factor (HGF) and its receptor, the MET transmembrane tyrosine kinase (cMET), are involved in embryogenesis, morphogenesis, and wound healing. The HGF-cMET axis promotes cell survival, proliferation, migration, and invasion via modulation of epithelial-mesenchymal interactions. Hepatocellular cancer (HCC) is the third most common cause of worldwide cancer-related mortality; advanced disease is associated with a paucity of therapeutic options and a five-year survival rate of only 10%. Dysregulation of the HGF-cMET pathway is implicated in HCC carcinogenesis and progression through activation of multiple signaling pathways; therefore, cMET inhibition is a promising therapeutic strategy for HCC treatment. The authors review HGF-cMET structure and function in normal tissue and in HCC, cMET inhibition in HCC, and future strategies for biomarker identification.Keywords
This publication has 89 references indexed in Scilit:
- Distinct Involvement of the Gab1 and Grb2 Adaptor Proteins in Signal Transduction by the Related Receptor Tyrosine Kinases RON and METOnline Journal of Public Health Informatics, 2011
- Structural basis for agonism and antagonism of hepatocyte growth factorProceedings of the National Academy of Sciences of the United States of America, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Identification and Confirmation of Biomarkers Using an Integrated Platform for Quantitative Analysis of Glycoproteins and Their GlycosylationsJournal of Proteome Research, 2009
- Directed Discovery of Agents Targeting the Met Tyrosine Kinase Domain by Virtual ScreeningJournal of Medicinal Chemistry, 2009
- Signaling networks assembled by oncogenic EGFR and c-MetProceedings of the National Academy of Sciences of the United States of America, 2008
- A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonistProceedings of the National Academy of Sciences of the United States of America, 2007
- Hepatocyte growth factor, transforming growth factor α, and their receptors as combined markers of prognosis in hepatocellular carcinomaMolecular Carcinogenesis, 2003
- Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinomaJournal of Hepatology, 1997
- Scatter factor is a fibroblast-derived modulator of epithelial cell mobilityNature, 1987